Clear Vascular Overview

  • Founded
  • 2005
Founded
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

Clear Vascular General Information

Description

Developer of pharmaceutical products designed to treat cardiovascular diseases. The company's Tin-Annexin is used for imaging and therapy of inflammatory tissues, initially targeting vulnerable and unstable plaque, enabling patients to begin treatment more quickly and result in a higher likelihood of a successful treatment.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Primary Office
  • 21 Waterway Avenue
  • Suite 225
  • The Woodlands, TX 77380
  • United States
+1 (631) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Clear Vascular Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Out of Business 01-Dec-2015 00.000 Completed Out of Business
5. Later Stage VC 30-May-2013 00000 00.000 Completed Generating Revenue
4. Grant 01-Jan-2013 00.00 00.000 Completed Generating Revenue
3. Later Stage VC (Series A) 29-Oct-2012 000 00.000 000.00 Completed Generating Revenue
2. Early Stage VC (Series A) 06-Aug-2010 $5.42M $5.42M 000.00 Completed Startup
1. Early Stage VC 01-Jan-2005 Completed Startup
To view Clear Vascular’s complete valuation and funding history, request access »

Clear Vascular Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00.000000 00 00.00 00.00 00.00 00.000
To view Clear Vascular’s complete cap table history, request access »